학술논문
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
Document Type
Artikel
Author
Source
Cancer immunology, immunotherapy : CII. 66(1):91-102
Subject
Language
English
English
English
ISSN
1432-0851